![Brian Daniels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Daniels
Président chez
ARTIVA BIOTHERAPEUTICS, INC.
Profil
Brian F.
Daniels currently works at Artiva Biotherapeutics, Inc., as Chairman from 2020, RareCyte, Inc., as Director, Inipharm, Inc., as Director from 2020, Transcelerate Biopharma, Inc., as Director, Medarex, Inc., as Director from 2009, Apexigen, Inc., as Advisor, and 5AM Venture Management LLC, as Venture Partner from 2014.
Dr. Daniels also formerly worked at Nohla Therapeutics, Inc., as Non-Executive Director, IDEAYA Biosciences, Inc., as Independent Director, Novo Nordisk Ltd., as Director, Spyryx Biosciences, Inc., as Director, Novo Nordisk A, as Independent Director from 2016 to 2021, Armaron Bio Ltd., as Director, Cabaletta Bio, Inc., as Independent Director from 2018 to 2021, Merck Research Laboratories Massachusetts LLC, as Principal, The Boston Consulting Group, as Senior Advisor from 2015 to 2018, Genentech, Inc., as Principal, and Bristol Myers Squibb Co., as Senior Vice President-Global Development from 2004 to 2014.
Dr. Daniels received his undergraduate degree in 1981 and graduate degree in 1981 from Massachusetts Institute of Technology and doctorate degree in 1987 from Washington University School of Medicine.
Postes actifs de Brian Daniels
| Sociétés | Poste | Début |
|---|---|---|
| ARTIVA BIOTHERAPEUTICS, INC. | Président | 01/06/2020 |
| APEXIGEN, INC. | Corporate Officer/Principal | - |
| CSL LIMITED | Directeur/Membre du Conseil | 01/12/2024 |
Inipharm, Inc.
 Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that develops therapies for liver and related diseases | Directeur/Membre du Conseil | 11/11/2020 |
RareCyte, Inc.
 RareCyte, Inc. Medical SpecialtiesHealth Technology Develops life science research and diagnostic | Directeur/Membre du Conseil | - |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Private Equity Investor | 14/11/2014 |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Directeur/Membre du Conseil | - |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Directeur/Membre du Conseil | 13/05/2011 |
Anciens postes connus de Brian Daniels
| Sociétés | Poste | Fin |
|---|---|---|
| CABALETTA BIO, INC. | Directeur/Membre du Conseil | 24/06/2021 |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Brian Daniels
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Spyryx Biosciences, Inc.
 Spyryx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for obstructive lung diseases | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Armaron Bio Ltd.
 Armaron Bio Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops cardioprotection and neuroprotection small molecules to reduce tissue damage for heart attacks | Electronic Technology |
RareCyte, Inc.
RareCyte, Inc. Medical SpecialtiesHealth Technology Develops life science research and diagnostic | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Nohla Therapeutics, Inc.
 Nohla Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular therapies for hematological disorders | Health Technology |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
The Boston Consulting Group | |
Cabaletta Bio, Inc.
 Cabaletta Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which discovers and develops engineered cell therapies for B cell-mediated autoimmune diseases | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Inipharm, Inc.
Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that develops therapies for liver and related diseases | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
